This update includes information on funding goals and current research.
NEW YORK, March 11 (GenomeWeb News) - The Translational Genomics Research Institute and the Children's Memorial Institute for Education and Research will try to use certain genomics technologies to identify links between pediatric illnesses and adult diseases, the groups said today.
Terms of the collaboration call for the institutes to hunt genetic markers associated with brain disorders such as schizophrenia, behavioral disorders, autism, multiple sclerosis, certain cancers, developmental defects, and autoimmune diseases, Mary Hendrix, president and scientific director for the Chicago-based CMIER, said in a statement.
TGen will provide CMIER with access to "a range" of genomic, genetic, and proteomic technologies, as well as bioinformatics, high-throughput sequencing, and gene expression-profiling capabilities, the groups said.
One goal of the partnership is to recognize how "genetic components" of certain pediatric diseases could be translated to the early detection and management of related adult diseases, said Hendrix, who is also professor of pediatrics at Northwestern University's Feinberg School of Medicine.
Hendrix told GenomeWeb News that CMIER plans to pay for the research by grants from the US National Institutes of Health, as well as philanthropists. However, CMIER scientists are currently performing with TGen staffers on cell culture research and microarray studies, she said, adding that the NIH has been funding this.